Buprenorphine subdermal implant and pentobarbital both improve sedation. Avoid or Use Alternate Drug. Limit use to patients for whom substitute remedy solutions are inadequate pentobarbital will minimize the level or outcome of suvorexant by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Check. Potent CYP3A4 inducers may possibly decrease suvorexant efficacy; if https://williamd554whq5.westexwiki.com/user